Beta Lactams Flashcards
3 classes of Beta Lactam Antibiotics:
Carbapenems, Aztreonam, Cephalosporins
Beta Lactam Antibiotics mechanism
• Similar mechanism to penicillin • Bind transpeptidases (penicillin-binding proteins/PBPs) • Prevent peptidoglycan crosslinking • Autolysis • Usually bactericidal • Potentially susceptible to beta lactamase
Carbapenems
Imipenem, meropenem, ertapenem, doripenem
• Resistant to cleavage by most β-lactamase
ESBL Extended Spectrum Beta Lactamase:
Plasmid-mediated bacterial enzymes
Confer resistance to most beta-lactam antibiotics • Penicillins, cephalosporins, aztreonam
Found only in gram-negative bacteria • Pseudomonas • Klebsiella • E. coli • Enterobacter • Salmonella • Serratia • Shigella
Drug of choice for ESBL bacteria:
Carbapenems:
Broad spectrum: • Gram (+) • Gram (-) including pseudomonas, enterobacter • Anaerobes including B. fragilis • Used in hospitalized patients
whats unique about Imipenem?
First commercially available carbapenem • Metabolized in kidneys • Loss of antibacterial effect • Nephrotoxic metabolites • Proximal tubule enzyme: dehydropeptidase I • Given with cilastatin (enzyme inhibitor)
Carbapenems adverse reactions:
Common side effects • Nausea, vomiting, diarrhea • Skin rash
Neurotoxicity • Seizures • Inhibition of GABA receptors • Especially at high doses or with renal failure • Lower risk with meropenem
Aztreonam
unique molecular stuff about it:
effective against:
administration:
synergy:
- Monobactam: β-lactam ring not fused to another ring
- Binds penicillin-binding protein 3 (PBP-3)
Only active against gram (-) bacteria • Does not bind PBP of gram (+) bacteria • No activity against gram (+) or anaerobes • Active against pseudomonas
• Intravenous administration (hospitalized patients) • Synergistic with aminoglycosides
key use for Aztreonam:
• Key niche: penicillin allergy b/c no cross reactivity in penicillin allergic patients
1st Generation Cephalosporins: covers: does not cover:
main uses:
- Cefazolin, cephalexin
- Developed to treat S. Aureus resistance to penicillin • Covers many gram (+) including S. Aureus (not MRSA) • Stable against S. Aureus beta lactamase • Does not cover enterococcus or listeria • Susceptible to gram negative beta lactamases
Main uses: • Surgical wound (skin) infections • Cefazolin given pre-op for prevention
2 nd Generation Cephalosporins:
Cefuroxime, Cefoxitin, Cefotetan
2 nd Generation Cephalosporins
• Developed to treat amoxicillin-resistant infections
Increased affinity for gram (-) PBPs
More resistant to beta lactamase
Increased gram (-) • H. influenza, Enterobacter, Proteus • E. coli, Klebsiella, Serratia, N. gonorrheae • Increased anaerobic coverage (B. fragilis)
2 nd Generation Cephalosporins uses:
• Cefuroxime (oral): • Otitis media (S. pneumonia, H. flu) • UTI in children (E. coli; no fluoroquinolones)
Cefoxitin/cefotetan (IV): • PID (covers Neisseria; also give doxycycline for Chlamydia) • Pre-op in children with appendicitis • E. coli • Covers gram negatives and some anaerobes • Usually given with metronidazole
3 rd Generation Cephalosporins
Ceftriaxone, Cefotaxime, Ceftazidime
3 rd Generation Cephalosporins:
coverage:
specific penetration aspect to know:
Broad gram (-) coverage • More resistance to beta lactamase enzymes • More gram (-) PBP affinity
Ceftriaxone, Cefotaxime: Poor coverage pseudomonas
Ceftazidime: Covers pseudomonas • Used in hospitalized patients with gram negative infections • Sepsis/pneumonia
Most achieve good CSF penetration (meningitis)